GH Research (NASDAQ:GHRS – Get Free Report) and Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk. Analyst Ratings This is a summary of […]
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price […]
Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month […]
Acrivon Therapeutics (NASDAQ:ACRV) Receives "Outperform" Rating from BMO Capital Markets themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
LADENBURG THALM/SH SH lowered shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat Ratings reports. Other equities analysts also recently issued research reports about the company. HC Wainwright reaffirmed a buy rating and issued a $20.00 price objective […]